The Tianma 65 m radio telescope at Shanghai

The Shanghai Tianma 65 m radio telescope(TMRT)is a large,fully rotatable radio telescope with multiple scientific purposes.The main body of the telescope and four low-frequency receiving systems,including L,C,and S/X bands,were completed between 2008 and 2012.From 2013 to 2017,four high-frequency receiving systems,including Ku,K,Ka,and Q bands,were constructed and their performance was comprehensively tested.There are three main innovations.(1)A fully movable large radio telescope system with advanced performance and complete functions has been built.(2)An advanced,reliable main reflector adjustment system has been completed,overcoming gravity deformation and creating a large antenna with a main reflective surface accuracy of 0.28 mm(root mean square)for any elevation.(3)Five innovative technologies have been developed to achieve high-precision pointing in any direction within 3″.The TMRT has made a crucial contribution to the orbital measurement and positioning of China’s lunar and deep space probes.Significantly enhancing China's ability to participate in international VLBI observations and radio astronomy,this has facilitated a series of achievements in observational radio astronomical research,in areas such as VLBI,spectral lines,and pulsars.

Advances in Research of Chinese Medicine Tianma in the Treatment of Parkinson's Disease

In this study,a systematic review was conducted on the experimental study as well as the clinical application of Tianma(Gastrodia elata Blume),a traditional Chinese medicine,in the prevention and treatment of Parkinson's disease(PD).On this basis,a summary and outlook were made,so as to provide ideas and theoretical basis for the study,development and utilization of Tianma PD field.

Clinical effects of Banxia Baizhu Tianma decoction in the treatment of hypertension

Objective:To observe the clinical effect of Banxia Atractylodes macrocephala Tianma decoction in the treatment of hypertension.Methods:A total of 100 patients with hypertension were selected from our hospital(April 2016 to July 2019)and divided into 2 groups by random digital method.The control group was given routine symptomatic treatment of western medicine,and the observation group was given Banxia Atractylodes Gastrodia decoction on the basis of the control group.the levels of syndrome score and adiponectin(apn),cysc(cysc),uric acid(ua),c-reactive protein(crp),superoxide dismutase(sod),malondialdehyde(mda),8-hydroxydeoxyguanylic acid(8-ohdg)were recorded before and after treatment in group 2,and the total effective rate of clinical treatment was counted in group 2.Results:After treatment,the total effective rate(92.00%)in the observation group was higher than that in the control group(74.00%),and the difference was statistically significant(P<0.05).The APN、SOD level of the observation group was higher than that of the control group after treatment,and the CysC、UA、CRP、MDA、8-OHdG level and TCM symptom score were lower than those of the control group(P<0.05).Conclusion:Rhizoma Pinelliae and Rhizoma Gastrodiae decoction for treating hypertension can relieve oxidative stress injury,adjust the expression level of APN,CysC,CRP and UA,and improve the symptoms and improve the curative effect.

Expert Consensus on the Clinical Application of Tianma Xingnao Capsule in the Treatment of Vascular Cognitive Impairment and Neuropathic Headache

The prescription of Tianma Xingnao Capsule is composed of Gastrodiae Rhizoma,Pheretima,Acori Tatarinowii Rhizoma,Polygalae Radix,Rehmanniae Radix Praeparata,and Cistanches Herba.It has effects of nourishing liver and kidney,dredging collaterals and relieving pain.More than 20 years of clinical application and evidence-based medical research have shown that Tianma Xingnao Capsule has a significant therapeutic effect on vascular cognitive impairment and neuropathic headache.In order to further guide the proper clinical use of this prescription,the consensus expert group conducted a comprehensive analysis of the prescription of Tianma Xingnao Capsule.Combining the existing evidence-based medicine evidence and the experience of clinical experts,this consensus report standardized the usage,dosage,duration and safety of Tianma Xingnao Capsule in the treatment of vascular cognitive impairment and neuropathic headache.It is expected to provide a theoretical basis for clinically reasonable and safe use of Tianma Xingnao Capsule.

A Meta-Analysis of Migraine Treated with Banxia Baizhu Tianma Decoction

Objective Our objective was to systematically evaluate the efficacy and safety of Banxia Baizhu Tianma decoction in the treatment of migraine.Methods The databases of China National Knowledge Infrastructure,VIP,WanFang,Chinese Biomedical Databases,PubMed,and EMbase were searched by computer,and randomized controlled trials that met the inclusion criteria were retrieved.The Cochrane bias risk assessment tool was used to evaluate the quality of the included studies.RevMan 5.3 software was used to conduct meta quantitative analysis of the included studies.Results A total of 19 studies were included,with a total sample size of 1,635 cases,821 cases in the treatment group and 814 cases in the control group.The results of meta-analysis showed that(1)the clinical effective rate of the single use of Banxia Baizhu Tianma decoction or western medicine combined with Banxia Baizhu Tianma decoction in treating migraine was better than that of western medicine alone(p<0.001);(2)the improvement in cumulative number and days of vertigo in the treatment of migraine with Banxia Baizhu Tianma decoction was observed in the control group(p<0.001).TSA results showed that Z-curve passed both the traditional threshold and Trial sequential analysis(TSA)threshold.In terms of adverse reactions,55 cases were reported,including 12 cases in the treatment group and 43 cases in the control group,and no serious adverse reactions were found.Conclusion Compared with the single use of western medicine therapy,the combination of Banxia Baizhu Tianma decoction and western medicine or the single use of Banxia Baizhu Tianma decoction could better improve the effective rate and showed good safety and low incidence of adverse reactions.

Tianma Microelectronics Co.Ltd.

Tianma Microelectronics Co.Ltd...

Systematic Review and Meta-analysis on the Efficacy and Safety of Tianma Gouteng Granules(天麻钩藤颗粒)in Treatment of Dizziness

Objective:The effectiveness and safety of Tianma Gouteng Granules(天麻钩藤颗粒)in the treatment of dizziness were systematically evaluated.Methods:A randomized controlled trial of Tianma Gouteng Granules for dizziness was screened out by searching CNKI,Wanfang Data,VIP,SinoMed,Cochrane Library,PubMed,Embase,Web of Science in a systematic way and was based on Handbook 5.1 evaluation criteria and tools and RevMan 5.3 software for meta-analysis of the final inclusion of the study.Results:A total of 7 studies were included,6 studies were included in meta-anlysis and 1 other study,with a total sample size of 568 cases,including 328 cases in the experiential group and 240 cases in the control group.The systolic pressure of Tianma Gouteng Granules alone or combined with conventional treatment in the treatment of dizziness is better than conventional treatment alone(MD=-3.38,95%CI[-4.90,-1.86],P<0.00001).The diastolic pressure of Tianma Gouteng Granules alone or combined with conventional treatment in the treatment of dizziness had no difference compared with conventional treatment alone(MD=-1.35,95%CI[-2.36,-0.34],P=0.72).The TCM syndromes score of Tianma Gouteng Granules alone or combined with conventional treatment in the treatment of dizziness was better than conventional treatment(MD=-5.18,95%CI[-6.89,-5.47],P<0.00001).The marked effective rate of Tianma Gouteng Granules combined with conventional treatment in the treatment of dizziness was better than conventional treatment(RR=2.09,95%CI[1.35,3.24],P=0.001).The marked effective rate of Tianma Gouteng Granules in the treatment of dizziness was better than conventional treatment(RR=1.85,95%CI[1.34,2.54],P=0.0002).Adverse actions included stomach discomfort,dry mouth,headache,dizziness,nausea,insomnia,rash,etc.The number of reported cases in both groups was small.Conclusion:The treatment of systolic pressure,TCM syndrome score and marked effective rate of Tianma Gouteng Granules alone or combined with conventional treatment for dizziness was better than conventional treatment.There was no difference between Tianma Gouteng Granules alone or combined with conventional treatment on diastolic pressure.No serial reverse actions were reported,and all reverse actions were reported after drug withdrawal or dose reduction,and the sample size was small,requiring large samples for further verification.However,the quality of the study is not high,and it is necessary to improve the level of evidence quality by using clinical trial schemes with large samples,rational design and compliance with international standards.

The Efficacy of Banxia Baizhu Tianma Decoction(半夏白术天麻汤)Combined with Xuefu Zhuyu Decoction(血府逐瘀汤)for Essential Hypertension and the Effects on Endothelial Function:A Systematic Review and Meta-analysis

Objective:Banxia Baizhu Tianma Decoction(半夏白术天麻汤,BBTD)combined with Xuefu Zhuyu Decoction(血府逐瘀汤,XFZYD)is widely used to treat essential hypertension in China,but its efficacy remains largely unexplored.We systemically summarized relevant evidence from randomized controlled trials(RCTs)to assess the therapeutic efficacy of BBTD+XFZYD.Methods:This review retrieved 6 databases like Pubmed,Cochrane Library,Embase,CNKI,et al.RCTs of BBTD+XFZYD plus conventional Western drugs(experimental group)and conventional Western drugs alone(control group)for hypertension was collected from the database establishment to August 5,2020.And the outcomes included clinical total effective rate,systolic blood pressure(SBP),diastolic blood pressure(DBP),nitric oxide(NO)and endothelin-1(ET-1).All studies’risk of bias were assessed by the Cochrane Collaboration tool 5.1.0.The data was statistically analyzed by RevMan5.3 Software.Results:Six studies with 608 participants were identified.About duration of treatment,4 studies were 1 month,2 studies were 2 months.The quality presented a high risk of bias.The experimental group showed that clinical total effective rate of the 1-month and 2-month was higher(P<0.00001),the systolic pressure was significantly lower(P<0.05),the NO increased(P<0.00001),and the ET-1 decreased(P<0.00001)compared with the conventional Western drugs used alone.However,DBP was significantly lower(P<0.05)at 2 months of treatment.Conclusion:BBTD+XFZYD plus conventional Western drugs might reduce blood pressure,improve clinical efficacy,repair endothelial function,but still need high-quality RCTs to better assess the outcomes.

Clinical Observation on the Treatment of Hypertension by Combination of Modified Banxia Baizhu Tianma Decoction and Auricular Acupuncture

Objective:To observe the curative effect of Jiawei Banxia Baizhu Tianma Decoction(BBTD)in combination with auricular acupuncture in the treatment of primary hypertension with phlegm-dampness syndrome.Methods:120 patients with hypertension were randomly divided into a pure Western medicine treatment control group(referred to as the control group)and an integrated traditional Chinese and Western medicine treatment group(referred to as the treatment group),with 60 cases in each group.The control group was given nifedipine sustained-release tablets orally;the treatment group:nifedipine sustained-release tablets were given on the basis of modified BBTD combined with auricular acupuncture.The treatment course duration of the two groups was 4 weeks.Before and after treatment,the two groups were evaluated for treatment efficacy and quality of life.Results:There is statistically significant difference in blood pressure lowering between the treatment group and the control group(P<0.05);the treatment group was better than the control group in symptoms improvement of the patients(P<0.05);in terms of the improvement in quality of life,the treatment group was significantly better than the control group(P<0.05,P<0.01).Conclusion:Modified BBTD combined with auricular acupuncture method can reduce blood pressure and improve clinical symptoms in patients with primary hypertension with phlegm-dampness syndrome,and significantly improve the quality of life of patients.

Application of network pharmacology in uncovering the biological basis of using the Banxia Baizhu Tianma decoction for hypertension treatment

Background:The Banxia Baizhu Tianma decoction(BBTD)is widely used in the clinical treatment of hypertension and has definite curative effects.However,its active ingredients and mechanism of action in hypertension treatment are still unknown.In this study,network pharmacology was used to elucidate the potential antihypertensive mechanism of BBTD.Methods:The active ingredients and targets of BBTD were screened in the pharmacological database of the Chinese medicine system.The targets that are related to hypertension were obtained from the Online Mendelian Inheritance in Man(OMIM),Drugbank,and Genecards databases.The String database was used to analyze the prevention and treatment of hypertension by BBTD.The interaction of important targets was assessed,and the related network data was visualized using the Cytoscape software.The OmicShare platform was employed in conducting enrichment analyses of gene functions and pathways of important targets,in addition to evaluating the relationship between important targets and the phenotype of hypertension.Molecular docking of the main active ingredients with important targets was also assessed.Results:In this study,194 main active ingredients and 616 targets of BBTD were screened,and 5,819 related targets that are closely related to hypertension were unearthed.A total of 445 BBTD key targets for the treatment of hypertension were obtained,along with 73 core targets from performed network topology and module analysis on the key targets.The enrichment analyses of GO and KEGG showed that oxidative stress,HIF-1 signal,IL-17 signal,and TNF signal play a vital role in hypertension.Molecular docking studies have revealed that the main biologically active components can be combined with key targets quite well.Conclusion:The potential mechanism of BBTD in treating hypertension involves many components,targets,and pathways.Some of the potential targets for the prevention and treatment of hypertension are ESR1,MAPK,TP53,TNF,and MMP9.These findings provide a reference for further research on the potential mechanism of action for the BBTD-based treatment of hypertension.

Decomposition and Reformulation of Banxia Baizhu Tianma Decoction:A Vasodilatory Approach

Objective To decompose and reformulate Banxia Baizhu Tianma Decoction（BBT） in order to optimize its ratio for vasodilatory effect.The fingerprints of these six component herbs were also studied via Tri-step FTIR analysis.Methods The herbal components of BBT were extracted separately with different solvents,such as 95%ethanol,50%ethanol,and distilled water.The vasodilatory effect of the extracts was studied using the in vitro pre-contracted aortic ring model.Among these extracts,the water extracts of Pinellia ternata[PT（W）]and Citri reticulatae[CR（W）],50%ethanol extracts of Castrodia elata[GE（50）]and Clycyrrhiza uralensis[GU（50）],and 95%ethanol extracts of Atractylodes macrocephala[AM（E）],and Poria cocos[PC（E）]were selected for the orthogonal stimulus-response compatibility group study due to their high effectiveness in vasodilation.Results The best combination ratio（G2） was GE（50）,GU（50）,AM（E）,PC（E）,CR（W）,and PT（W） at EC0,EC5,EC5,EC5,EC5,and EC5,with EC50 of（0.06 ± 0.01） mg/mL.Comparison between the vasodilatory effects of extracts derived from G2 and BBT were also studied.From the results,the 50%ethanol extract following G2 ratio was found to be most potent extract with the highest vasodilatory effect compared with other extracts derived from G2 or BBT,with EC50 of（0.05 ±0.005） mg/mL.Conclusion The optimum ratio and appropriate extraction method for the new BBT formulae are obtained.G2 is determined as the best formulae with the highest potency in producing the vasodilatory effect on isolated rat aortic rings.The results obtained suggest that 50%ethanol is found to be the best solvent to extract the vasoactive compounds of G2 in order to exhibit the highest efficacy of vasodilatory effect.

眩晕项贴联合半夏白术天麻汤加减对肝火上炎型耳石症复位后残余眩晕的临床疗效观察

目的探讨眩晕项贴联合半夏白术天麻汤加减治疗肝火上炎型耳石症复位后残余眩晕的临床疗效。方法前瞻性选取2020年1月至2023年1月北京中医药大学东直门医院通州院区收治的肝火上炎型耳石症复位后残余眩晕患者74例作为研究对象,按随机数字表法将其分为对照组(n=37)和试验组(n=37)。对照组采用单纯予以甲磺酸倍他司汀片治疗,餐后口服,12 mg/次,3次/d,7 d为1个疗程,共治疗1个疗程;试验组采用眩晕项贴联合半夏白术天麻汤加减治疗,早晚各服1次,疗程2周。观察两组患者的临床疗效,比较两组患者治疗前和治疗2周后的眩晕障碍量表(DHI)评分、前庭症状指数(VSI)评分、血流动力学(血浆黏度、纤维蛋白原、红细胞比容)指标、血流速度[左侧椎动脉(LVA)、右侧椎动脉(RVA)和基底动脉(BA)]的差异。结果治疗后,试验组临床总有效率为100.00%,显著高于对照组(83.78%),差异有统计学意义(P<0.05)。治疗2周后,两组DHI评分和VSI评分均较治疗前显著降低,且试验组DHI评分和VSI评分分别为(10.57±2.31)、(14.62±3.56)分,均显著低于对照组[(15.71±2.63)、(25.14±4.62)分],差异均有统计学意义(P<0.05)。治疗2周后,两组血浆黏度、红细胞比容及纤维蛋白原水平均较治疗前显著降低,且试验组血浆黏度、红细胞比容及纤维蛋白原水平分别为(0.83±0.15)mPa·s、(0.24±0.06)%、(41.24±4.52)%,均显著低于对照组[(1.12±0.23)mPa·s、(0.36±0.07)%、(47.51±3.56)%],差异均有统计学意义(P<0.05)。治疗2周后,两组LVA、RVA、BA水平均较治疗前升高,且试验组LVA、RVA、BA水平分别为(31.24±4.28)、(28.79±4.01)、(40.52±4.73)cm/s,均显著高于对照组[(22.45±4.67)、(22.71±4.58)、(29.42±5.01)cm/s],差异均有统计学意义(P<0.05)。结论眩晕项贴联合半夏白术天麻汤加减治疗肝火上炎型耳石症复位后残余眩晕患者可提高临床疗效,减轻眩晕障碍及前庭症状,同时还可有效改善其血流动力学,值得临床推广应用。

天麻首乌片致严重肝损伤1例分析

目的 探讨严重肝损伤与天麻首乌片的相关性。方法 通过1例服用天麻首乌片导致严重肝损伤的不良反应,梳理其组方中药肝毒性的文献研究结果,采用《中国药物性肝损伤诊治指南(2023年版)》相关标准及更新后的RUCAM量表对肝损伤分型及与天麻首乌片的因果关系进行评估,探讨治疗策略的合理性。结果 天麻首乌片中制何首乌和炒蒺藜可能造成肝损伤,本例患者肝损伤为肝细胞损伤型,RUCAM评分7分(很可能),治疗策略通常包括保肝、利胆、抗炎等。文献分析发现,人类白细胞抗原(HLA)-B*35:01等位基因是何首乌肝损伤的风险因素,可作为预测何首乌所致肝损伤的潜在生物标志物。结论 本例患者严重肝损伤与天麻首乌片存在相关性;药品上市许可持有人应主动监测相关品种的不良反应,并及时更新说明书,减少患者用药风险。

半夏白术天麻汤合通窍活血汤联合治疗痰瘀互结型高血压颈动脉斑块疗效及对中医证候积分和血脂代谢的影响

目的:观察半夏白术天麻汤合通窍活血汤联合治疗痰瘀互结型高血压(HTN)颈动脉斑块疗效及对中医证候积分和血脂代谢的影响。方法:选取我院2021年1月~2022年6月收治的HTN伴颈动脉斑块患者62例。按照随机数字表法将患者分为治疗组(n=31)与对照组(n=31),两组均予以基础治疗,对照组以西药服用治疗,治疗组以西药+半夏白术天麻汤合通窍活血汤治疗,比较治疗后临床疗效,治疗前后中医症候积分、血压监测、血脂水平、超声检查[颈动脉内膜-中层厚度(IMT)、Grouse积分]、实验室指标[同型半胱氨酸(Hcy)、C反应蛋白(CRP)]。结果:治疗4个疗程后,治疗组临床疗效为28/31(90.32%)较对照组22/31(70.97%)更高(P<0.05);两组中医证候积分、收缩压(SBP)、舒张压(DBP)、低密度脂蛋白(LDL-C)、总胆固醇(TC)、甘油三酯(TG)、IMT、Crouse积分、血清Hcy、CRP水平均降低(P<0.05),且治疗组降幅高于对照组(P<0.05);两组高密度脂蛋白(HDL-C)均升高(P<0.05),且治疗组升幅高于对照组(P<0.05)。结论:半夏白术天麻汤合通窍活血汤联合治疗痰瘀互结型HTN伴颈动脉斑块可通过调节血脂代谢及血压水平,有效促进斑块消除,进而改善患者临床症状。

天麻钩藤饮对自发性高血压大鼠血管重塑的抑制作用及对NOX2/ROS通路、内质网应激的影响

目的研究天麻钩藤饮对自发性高血压大鼠(spontaneously hypertensive rats,SHR)血管重塑的抑制作用及机制。方法将大鼠随机分为正常对照组、模型组、厄贝沙坦组和天麻钩藤饮组。给药过程中每周测量大鼠尾动脉压;给药4周后,HE染色检测胸主动脉组织情况,测量与计算内膜-中层厚度(intima-media thickness,IMT)、内膜-中层厚度/管腔直径(lumen diameter,LD),同时扫描电镜检查组织形态变化;免疫组织化学测定NADPH氧化酶2(NADPH oxidase 2,NOX2)、C/EBP同源蛋白(C/EBP homologous protein,CHOP)、葡萄糖调节蛋白78(glucose-regulating protein 78,GRP78)蛋白的表达情况;ELISA测定血浆中活性氧(reactive oxygen species,ROS)含量。结果(1)尾动脉压检测:与正常对照组比较,模型组大鼠收缩压均显著升高(P<0.05);与模型组比较,给药第1周起各治疗组大鼠收缩压均下降(P<0.05)。(2)胸主动脉组织形态学检测:扫描电镜可见模型组胸主动脉壁较正常对照组明显增厚;与模型组比较,各治疗组胸主动脉壁厚度均降低。HE染色观察可见正常对照组胸主动脉血管结构正常,未见动脉管壁增生;模型组胸主动脉壁明显增厚,单位面积细胞核数量增多;与模型组比较,各治疗组胸主动脉壁厚度、单位面积细胞核数量均减少。与正常对照组比较,模型组胸主动脉IMT、IMT/LD增加(P<0.05);与模型组比较,各治疗组胸主动脉IMT、IMT/LD下降(P<0.05)。(3)免疫组织化学检测胸主动脉中NOX2、CHOP、GRP78蛋白表达水平:与正常对照组比较,模型组血管壁NOX2、CHOP、GRP78蛋白表达水平显著上升(P<0.05);与模型组比较,各治疗组血管壁NOX2、CHOP、GRP78蛋白表达均下降(P<0.05)。(4)ELISA测定血浆中ROS含量:与正常对照组比较,模型组大鼠血浆中ROS含量显著上升(P<0.05);与模型组比较,各治疗组ROS含量显著下降(P<0.05)。结论天麻钩藤饮在降压的同时抑制血管重塑,其机制可能与抑制NOX2/ROS通路介导的内质网应激有关。

健脾化痰法联合前庭康复训练治疗良性阵发性位置性眩晕残余症状的临床研究

目的:观察健脾化痰法联合前庭康复训练治疗良性阵发性位置性眩晕(BPPV)残余症状的临床疗效。方法:临床收集BPPV经手法复位治疗后仍存残余症状患者60例,按随机数字表法分为治疗组和对照组,每组30例。对照组予前庭康复训练治疗,治疗组在对照组基础上加用半夏白术天麻汤加减口服治疗。观察两组患者残余头晕持续时间、眩晕残障量表(DHI)评分、中医证候积分及血液流变学指标,进行临床疗效分析。结果:治疗组残余头晕持续时间较对照组缩短,差异有统计学意义(P<0.05);治疗组DHI量表总评分、DHI量表躯体(P)、情感(E)和功能(F)评分及中医证候积分均明显低于对照组,差异有统计学意义(P<0.01,P<0.001),且总有效率较对照组明显提高,差异有统计学意义(P<0.05);血液流变学指标比较,治疗后,对照组全血高切黏度、血浆黏度及纤维蛋白水平与治疗组全血高切黏度、全血低切黏度、血浆黏度及纤维蛋白水平均较治疗前降低,且治疗组较对照组降低更明显,差异有统计学意义(P<0.05,P<0.01,P<0.001)。结论:应用健脾化痰法联合前庭康复训练治疗BPPV残余症状具有较好的临床疗效,值得推广。

中医推拿联合天麻钩藤饮加减治疗椎动脉型颈椎病的效果观察

目的研讨中医推拿联合天麻钩藤饮加减治疗椎动脉型颈椎病的效果。方法选择80例因椎动脉型颈椎病收治入院的患者作为本次研究对象,根据临床实验要求,将患者随机分成对照组(40例)和观察组(40例)。对照组给予中医推拿治疗,观察组给予中医推拿联合天麻钩藤饮加减治疗。均经过为期3个月的规范化治疗。比较两组患者治疗前后症状改善情况、生活质量及治疗效果。结果治疗后,观察组头晕、头痛、肢体麻木、颈部不适评分分别为(2.63±0.47)、(2.35±0.61)、(2.54±0.23)、(2.20±0.14)分显著低于对照组的(3.83±0.71)、(4.17±0.50)、(3.86±0.74)、(3.98±0.07)分(P<0.05);观察组总有效率为92.50%,明显高于对照组的60.00%(P<0.05);治疗后,观察组躯体功能评分(84.41±13.22)分、情感变化评分(86.12±14.25)分、社会功能评分(93.17±18.14)分显著高于对照组的(63.31±9.56)、(72.01±10.12)、(80.13±13.12)分(P<0.05)。结论中医推拿联合天麻钩藤饮加减治疗椎动脉型颈椎病具有良好的治疗效果,值得临床普及使用。

温胆汤合半夏白术天麻汤联合常规西药对颅脑外伤后眩晕的疗效分析

目的分析常规西医治疗颅脑外伤后眩晕的基础上联合温胆汤合半夏白术天麻汤的疗效。方法选取2019年1月—2023年12月江苏省连云港市赣榆区人民医院收治的64例颅脑外伤后眩晕患者为研究对象,根据不同治疗方案分为两组,各32例。对照组采用常规西药治疗,观察组采用常规西药+温胆汤合半夏白术天麻汤治疗。比较两组眩晕障碍程度评分、治疗有效性及不良反应发生率。结果治疗后,观察组眩晕障碍程度评分为(8.26±1.03)分,低于对照组的(15.75±1.01)分,差异有统计学意义(t=29.371,P<0.05)。观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。观察组的不良反应总发生率低于对照组,差异有统计学意义(P<0.05)。结论治疗颅脑外伤后眩晕时,可在常规西医治疗的基础上加用温胆汤合半夏白术天麻汤,有助于改善眩晕程度,提高治疗有效性,安全性较佳。

半夏白术天麻汤在急性脑梗死患者中的应用效果研究

探析半夏白术天麻汤在急性脑梗死患者临床治疗中的应用效果及治疗有效率。选取贵阳市第一人民医院神经科于2022年1月—2022年12月收治的80例急性脑梗死患者作为研究对象,依据治疗方式的不同将所选患者随机平均分成对照组与观察组,每组分别纳入目标对象40例。对照组患者采用常规西医药物治疗方法,观察组患者采用半夏白术天麻汤中医治疗方法。观察两组患者临床治疗效果、治疗总有效率、血液流变学相关指标,不良反应发生率以及生活质量。研究发现,急性脑梗死患者的临床治疗中积极采用半夏白术天麻汤中医治疗方式,能够明显改善患者神经功能,增强患者日常生活能力,提升临床治疗总有效率,控制患者病情恶化,且此种治疗方式具有安全、无副作用的特点,可以降低不良反应发生率,促进患者尽快恢复。

天麻钩藤饮联合硫酸镁、拉贝洛尔对妊娠期高血压患者的降压效果及血液流变学的影响评价

【目的】观察天麻钩藤饮联合硫酸镁、拉贝洛尔对妊娠期高血压患者的降压效果及血液流变学的影响。【方法】将90例妊娠期高血压肝阳偏亢型患者随机分为联合组和对照组,每组各45例。对照组给予硫酸镁联合拉贝洛尔治疗,联合组在对照组的基础上加用天麻钩藤饮治疗,疗程为5 d。观察2组患者治疗前后收缩压、舒张压、尿蛋白水平及血液流变学指标的变化情况,比较2组患者的不良妊娠结局、不良反应及满意度情况,并以Logistic回归分析法探讨妊娠期高血压患者不良妊娠结局的影响因素。【结果】(1)降压效果方面,治疗后,2组患者的收缩压、舒张压和尿蛋白水平均较治疗前明显降低(P<0.05),且联合组的降低程度均明显优于对照组(P<0.01)。(2)血液流变学方面,治疗后,2组患者的血浆黏度、全血黏度和红细胞比容均较治疗前明显降低(P<0.05),且联合组的降低程度均明显优于对照组(P<0.05或P<0.01)。(3)不良妊娠结局方面,联合组的不良妊娠结局总发生率为11.11%(5/45),明显低于对照组的33.33%(15/45),差异有统计学意义(P<0.05)。(4)满意度方面,联合组的满意度为97.78%(44/45),明显高于对照组的84.44%(38/45),差异有统计学意义(P<0.05)。(5)不良反应方面,联合组的不良反应总发生率为13.33%(6/45),对照组为8.89%(4/45),组间比较,差异无统计学意义(P>0.05)。(6)影响因素方面,经Logistic回归分析,未使用天麻钩藤饮联合拉贝洛尔、硫酸镁治疗及降压效果不佳均是妊娠期高血压患者不良妊娠结局的独立危险因素(均OR>1,P<0.05)。【结论】天麻钩藤饮联合拉贝洛尔、硫酸镁中西医结合治疗妊娠期高血压患者的降压效果确切,能有效改善血液流变学指标以及不良妊娠结局,提升患者的满意度。